| GOLDMAN SACHS US CORE EQUITY PORTFOLIO P (SNAP) USD CAP | RVI USA | 18,31% | 52,36% | 63,70% | 225,43% |
| AB SICAV I-GLOBAL VALUE PORTFOLIO S1 EUR | RVI GLOBAL VALOR | 40,16% | 59,23% | 63,68% | 147,78% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | BIOTECNOLOGÍA | 48,67% | 52,32% | 63,66% | 169,53% |
| CT (LUX) US CONTRARIAN CORE EQUITIES IE EUR | RVI USA | 23,31% | 53,69% | 63,66% | 222,80% |
| DWS INVEST II GLOBAL EQUITY HIGH CONVICTION LD | RVI GLOBAL | 27,90% | 63,81% | 63,66% | 195,85% |
| GOLDMAN SACHS US CORE EQUITY PORTFOLIO OTHER CURRENCY (CLOSE) SGD CAP | RVI USA | 23,19% | 51,40% | 63,66% | · |
| SCHRODER ISF US LARGE CAP C DIS USD | RVI USA | 13,99% | 51,41% | 63,66% | 211,32% |
| CT (LUX) US CONTRARIAN CORE EQUITIES IU USD | RVI USA | 24,36% | 53,91% | 63,65% | 222,41% |
| UBS (LUX) EQUITY SICAV - USA GROWTH (USD) I-A1-ACC | RVI USA CRECIMIENTO | 25,55% | 69,01% | 63,65% | 312,54% |
| BRANDES EMERGING MARKETS VALUE FUND A EUR CAP | RVI EMERGENTES | 52,61% | 73,49% | 63,64% | 112,66% |
